vs

Side-by-side financial comparison of BigBear.ai Holdings, Inc. (BBAI) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $27.3M, roughly 1.3× BigBear.ai Holdings, Inc.). On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs -37.7%). PRECISION BIOSCIENCES INC produced more free cash flow last quarter ($-11.3M vs $-22.1M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs -9.2%).

BigBear.ai Holdings, Inc. develops and delivers artificial intelligence-powered decision support and analytics solutions. Its core offerings cover predictive analytics, supply chain optimization, and operational intelligence platforms, serving key segments including national defense, intelligence agencies, and commercial enterprise clients primarily across North America, helping customers improve operational efficiency and mitigate risks.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

BBAI vs DTIL — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.3× larger
DTIL
$34.2M
$27.3M
BBAI
Growing faster (revenue YoY)
DTIL
DTIL
+5298.8% gap
DTIL
5261.1%
-37.7%
BBAI
More free cash flow
DTIL
DTIL
$10.8M more FCF
DTIL
$-11.3M
$-22.1M
BBAI
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
-9.2%
BBAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BBAI
BBAI
DTIL
DTIL
Revenue
$27.3M
$34.2M
Net Profit
$20.1M
Gross Margin
20.3%
Operating Margin
-295.0%
36.6%
Net Margin
58.9%
Revenue YoY
-37.7%
5261.1%
Net Profit YoY
213.5%
EPS (diluted)
$0.17
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBAI
BBAI
DTIL
DTIL
Q4 25
$27.3M
$34.2M
Q3 25
$33.1M
$13.0K
Q2 25
$32.5M
$18.0K
Q1 25
$34.8M
$29.0K
Q4 24
$43.8M
$638.0K
Q3 24
$41.5M
$576.0K
Q2 24
$39.8M
$49.9M
Q1 24
$33.1M
$17.6M
Net Profit
BBAI
BBAI
DTIL
DTIL
Q4 25
$20.1M
Q3 25
$2.5M
$-21.8M
Q2 25
$-228.6M
$-23.5M
Q1 25
$-62.0M
$-20.6M
Q4 24
Q3 24
$-15.1M
$-16.4M
Q2 24
$-14.4M
$32.7M
Q1 24
$-127.8M
$8.6M
Gross Margin
BBAI
BBAI
DTIL
DTIL
Q4 25
20.3%
Q3 25
22.4%
Q2 25
25.0%
Q1 25
21.3%
Q4 24
37.4%
Q3 24
25.9%
Q2 24
27.8%
Q1 24
21.1%
Operating Margin
BBAI
BBAI
DTIL
DTIL
Q4 25
-295.0%
36.6%
Q3 25
-66.0%
-158976.9%
Q2 25
-278.1%
-121538.9%
Q1 25
-61.0%
-76248.3%
Q4 24
-18.6%
Q3 24
-25.4%
-3693.6%
Q2 24
-41.9%
48.4%
Q1 24
-296.1%
-23.8%
Net Margin
BBAI
BBAI
DTIL
DTIL
Q4 25
58.9%
Q3 25
7.6%
-167476.9%
Q2 25
-704.0%
-130666.7%
Q1 25
-178.3%
-70913.8%
Q4 24
Q3 24
-36.5%
-2851.6%
Q2 24
-36.3%
65.6%
Q1 24
-385.8%
48.8%
EPS (diluted)
BBAI
BBAI
DTIL
DTIL
Q4 25
$0.17
$2.62
Q3 25
$-0.03
$-1.84
Q2 25
$-0.71
$-2.13
Q1 25
$-0.25
$-2.21
Q4 24
$-0.47
Q3 24
$-0.06
$-2.25
Q2 24
$-0.06
$4.67
Q1 24
$-0.68
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBAI
BBAI
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$87.1M
$115.6M
Total DebtLower is stronger
$107.0M
Stockholders' EquityBook value
$611.9M
$92.2M
Total Assets
$894.5M
$154.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBAI
BBAI
DTIL
DTIL
Q4 25
$87.1M
$115.6M
Q3 25
$456.6M
$44.9M
Q2 25
$390.8M
$62.2M
Q1 25
$107.6M
$77.2M
Q4 24
$50.1M
$86.3M
Q3 24
$65.6M
$101.2M
Q2 24
$72.3M
$123.6M
Q1 24
$81.4M
$137.8M
Total Debt
BBAI
BBAI
DTIL
DTIL
Q4 25
$107.0M
Q3 25
$104.9M
Q2 25
$103.0M
Q1 25
$101.4M
Q4 24
$136.2M
Q3 24
$195.7M
Q2 24
$195.7M
Q1 24
$195.6M
Stockholders' Equity
BBAI
BBAI
DTIL
DTIL
Q4 25
$611.9M
$92.2M
Q3 25
$610.0M
$16.6M
Q2 25
$266.6M
$34.1M
Q1 25
$197.8M
$49.3M
Q4 24
$-3.7M
$56.4M
Q3 24
$127.5M
$64.9M
Q2 24
$134.7M
$74.7M
Q1 24
$143.2M
$37.2M
Total Assets
BBAI
BBAI
DTIL
DTIL
Q4 25
$894.5M
$154.4M
Q3 25
$919.8M
$93.5M
Q2 25
$599.4M
$108.9M
Q1 25
$396.3M
$124.4M
Q4 24
$343.8M
$136.4M
Q3 24
$354.1M
$153.3M
Q2 24
$360.9M
$165.8M
Q1 24
$377.6M
$184.7M
Debt / Equity
BBAI
BBAI
DTIL
DTIL
Q4 25
0.17×
Q3 25
0.17×
Q2 25
0.39×
Q1 25
0.51×
Q4 24
Q3 24
1.54×
Q2 24
1.45×
Q1 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBAI
BBAI
DTIL
DTIL
Operating Cash FlowLast quarter
$-21.8M
$-11.3M
Free Cash FlowOCF − Capex
$-22.1M
$-11.3M
FCF MarginFCF / Revenue
-80.9%
-32.9%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBAI
BBAI
DTIL
DTIL
Q4 25
$-21.8M
$-11.3M
Q3 25
$-9.6M
$-15.3M
Q2 25
$-3.9M
$-20.3M
Q1 25
$-6.7M
$-19.1M
Q4 24
$-14.8M
$-58.4M
Q3 24
$-1.9M
$-5.9M
Q2 24
$-7.1M
$-14.9M
Q1 24
$-14.4M
$-19.0M
Free Cash Flow
BBAI
BBAI
DTIL
DTIL
Q4 25
$-22.1M
$-11.3M
Q3 25
$-9.8M
Q2 25
$-3.9M
$-20.3M
Q1 25
$-6.7M
$-19.1M
Q4 24
$-15.0M
$-58.7M
Q3 24
$-2.0M
$-6.0M
Q2 24
$-7.2M
$-14.9M
Q1 24
$-14.4M
$-19.1M
FCF Margin
BBAI
BBAI
DTIL
DTIL
Q4 25
-80.9%
-32.9%
Q3 25
-29.5%
Q2 25
-11.9%
-112627.8%
Q1 25
-19.4%
-65917.2%
Q4 24
-34.2%
-9199.8%
Q3 24
-4.9%
-1033.2%
Q2 24
-18.1%
-29.9%
Q1 24
-43.5%
-108.4%
Capex Intensity
BBAI
BBAI
DTIL
DTIL
Q4 25
0.9%
0.1%
Q3 25
0.6%
0.0%
Q2 25
0.0%
11.1%
Q1 25
0.2%
220.7%
Q4 24
0.4%
39.2%
Q3 24
0.3%
6.8%
Q2 24
0.3%
0.1%
Q1 24
0.1%
0.5%
Cash Conversion
BBAI
BBAI
DTIL
DTIL
Q4 25
-0.56×
Q3 25
-3.80×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons